| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $44.1M | +17.2% |
| SG&A Expense | $15.1M | +11.8% |
| Operating Income | -$70.9M | -38.7% |
| Interest Expense | $13K | -92.0% |
| Income Tax | $0 | — |
| Net Income | -$70.1M | -36.9% |
| EPS (Basic) | -$2.19 | -25.1% |
| EPS (Diluted) | -$2.19 | -25.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.4M | +3.8% |
| Current Assets | $54.8M | -45.1% |
| Total Assets | $54.9M | -50.0% |
| Current Liabilities | $8.1M | -4.4% |
| Total Liabilities | $8.1M | -4.4% |
| Stockholders' Equity | $46.8M | -53.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.5M | -19.8% |
| Capital Expenditures | $472K | -76.7% |
| Investing Cash Flow | $43.4M | +185.4% |
| Financing Cash Flow | $8.7M | -88.1% |
| Free Cash Flow | -$52.0M | -15.5% |